MedPath

Neomycin and Polymyxin B Sulfates and Hydrocortisone

Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Solution USP (Sterile)

Approved
Approval ID

5af59404-0604-4d1b-865f-b72425622760

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-0708
Application NumberANDA064053
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin Sulfate, Polymyxin B Sulfate, Hydrocortisone
Product Specifications
Route of AdministrationAURICULAR (OTIC)
Effective DateApril 27, 2011
FDA Product Classification

INGREDIENTS (9)

GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
NEOMYCIN SULFATEActive
Quantity: 3.5 mg in 1 mL
Code: 057Y626693
Classification: ACTIB
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIB
HYDROCORTISONEActive
Quantity: 10 mg in 1 mL
Code: WI4X0X7BPJ
Classification: ACTIB
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
POTASSIUM METABISULFITEInactive
Code: 65OE787Q7W
Classification: IACT
CUPRIC SULFATEInactive
Code: LRX7AJ16DT
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 1/31/2011

Rx only

FOR USE IN THE EARS ONLY
NOT FOR USE IN THE EYES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Neomycin and Polymyxin B Sulfates and Hydrocortisone - FDA Drug Approval Details